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Abstract: In this study we pursued a diagnostic target in Aspergillus fumigatus (AF) by 
using qualitative Realtime PCR combined with proprietary DNA primers and a hydrolysis 
probe specific for this fungal target. Qualitative Realtime PCR is a diagnostic tool that 
utilizes Realtime PCR technology and detects the presence or absence target specific DNA 
within a predetermined detection range. Respiratory tissue and fluids from experimentally 
infected  guinea  pigs  were  tested  by  extracting  DNA  from  the  samples  which  were 
amplified and detected using AF specific DNA primers and probe. This study included 
qualitative evaluations of all specimens for the presence of the DNA of AF. The findings in 
the  tissues  after  AF  infection  were  compared  to  the  numbers  of  spores  in  aerosolized 
samples used to inoculate the animals. Results demonstrated that the specific probe and 
primer set could detect the presence or absence of AF DNA in the sample. The qualitative 
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detection limit of the assay ranged from 6 ×  10
4 copies to 6 copies. Since blood cultures are 
rarely  positive  for  Aspergillosis,  our  data  indicate  that  qualitative  Realtime  PCR,  in 
combination  with  the  appropriate  DNA  primers  and  probe  can  serve  as  an  effective 
diagnostic tool in the early detection of fungal infections.  
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1. Introduction  
Invasive  fungal  infections  are  the  most  common  infections  observed  in  immunocompromised 
patients [1]. The incidence of invasive aspergillosis (IA) and other fungal infections has increased 
significantly over recent decades because of the increasing numbers of surviving immunocompromised 
patients [2]. Fungal infections in adults and children have been extensively studied; however, the speed 
necessary to slow these infections and identify the causative organism has fallen short in the effort to 
reduce  the  mortality  in  these  patients  [3].  The  incidence  of  infectious  aspergillosis  has  increased 
dramatically over the past two decades in bone marrow transplant recipients [4], yet the ability to 
diagnose these infections has not increased substantially in laboratory medicine. In the United States 
alone, greater than 27,000 solid organ transplant procedures were performed in 2008 [5]. Pappas et al., 
in  2010  [6],  reported  a  slight  detectable  increase  in  invasive  fungal  infections  (IFIs)  during  a 
surveillance period of solid organ transplant patients in the U.S. during the period of 2002–2005. They 
further reported that a large number of IFIs occurred later than 1 year after transplantation, with as 
many as 25% of IFIs developing later than 3 years after transplantation. They suggested that these data 
indicated that prevention, diagnostic and treatment strategies need to be further developed to take these 
late developing infections into account. 
At present, patients suspected of having a fungal infection are subjected to multiple blood, urine, 
tissue, and other body fluid cultures. Fluid specimens are placed in blood culture bottles and on various 
selective media and cultured at room temperature and 37 ° C for various periods of time. The shortest 
period of time that various automated microbiological methods can detect fungal infections is 8–12 h, 
with the longest period of time in automated methods and/or culture media methods being as long as 
2–4 weeks. Culture techniques such as these also lack sensitivity. Patterson [7] provided a framework 
for evaluating genomic targets in animal models to improve the diagnosis and treatment of invasive 
aspergillosis. This framework evaluated an enzyme linked immunosorbent assay (ELISA) technique 
that allows for the detection of galactomannan from Aspergillus fumigatus (AF) [7,8] and incorporates 
other  biomarkers,  such  as  PCR-based  diagnosis  platforms.  As  Patterson  pointed  out,  the 
galactomannan detection in serum and other body fluids, especially bronchoalveolar lavage (BAL) 
fluid, plays a major role at present in non-culture based diagnosis of IA [7]. However, the sensitivity 
and specificity of the galactomannan assay is low and fraught with many false negatives and false 
positives [8,9]. 
Methods utilizing biological molecular techniques, such as polymerase chain reaction (PCR) or 
various types of nucleic acid blots, which take time and have serious contamination problems, are 
currently  available  and  used  in  many  laboratories  for  this  type  of  testing.  However,  Realtime Int. J. Mol. Sci. 2012, 13  728 
 
 
Polymerase  Chain  Reaction  (Realtime  PCR)  offers  a  clean,  closed  system  which  is  not  prone  to 
contamination  observed  with  other  techniques.  Realtime  PCR  instruments  such  as  the  Cepheid 
SmartCycler
® and the Applied Biosystems
TM 7500 Fast were used for these studies and provided an 
instrument  platform  capable  of  determining  the  presence  or  absence  of  AF  DNA  and  virtually 
eliminates contamination issues prevalent in open system instruments [10–12]. This paper describes 
work conducted using qualitative Realtime PCR which is a diagnostic tool that utilizes Realtime PCR 
technology and detects the presence or absence target specific DNA within a predetermined detection 
range. Qualitative detection assays have been previously described and are currently in use in clinical 
laboratories worldwide [13–15]. 
Realtime PCR based methods can be used to amplify, detect and identify specific fungal DNA by 
utilization  of  target  specific  primers  and  probes.  Realtime  PCR,  using  hydrolysis  probes  [16–17], 
combines  amplification  and  simultaneous  probe  hybridization  to  achieve  sensitive  and  specific 
detection of infectious fungi (e.g., molds) in Realtime, thereby providing rapid detection of opportunistic 
fungal pathogens such as AF, A. flavus, A. niger and A. terreus. Diagnostic tools available to a clinical 
lab in the mycology arena are extremely limited. Furthermore, successful treatment outcomes of fungal 
infections are predicated on effective, early, and sensitive/specific laboratory tests [7]. In the assay 
described here, primers and a probe were designed to amplify and detect a 136 base pair region on the 
18S Ribosomal RNA gene of AF. The assay was optimized and validated as directed by the Clinical 
and Laboratory Institute (CLSI) [18–20]. Efficiency, accuracy, precision, analytical sensitivity (detection 
limit), and analytical specificity (interfering substances) were the performance characteristics determined 
in this test with the amplification efficiency of the assay being within the acceptable range of 90 to  
105% and the linear standard curve (R
2) greater than 0.980. Furthermore, the test was audited and 
approved for human diagnostic purposes by the Centers for Medicare and Medicaid Services (CMS) 
and the College of American Pathologists (CAP). After inspections of the laboratory, validations and 
procedures were found to be compliant with Clinical Laboratory Improvement Amendments (CLIA), 
the test was approved for human molecular diagnostic testing.  
In this study, we examined one such promising and untapped diagnostic target in AF by using 
qualitative Realtime PCR combined with the proprietary DNA primers and a hydrolysis probe specific 
for this fungal target. Respiratory tissue and fluids from experimentally infected guinea pigs were 
tested by extracting DNA from the samples and amplified and detected using the AF specific DNA 
primers and probe described above.  
This study provides data comparing the number of spores found in tissues after infection, with the 
numbers of conidia in aerosolized samples used to inoculate the animals by semi quantitative culture. 
In addition, this study includes qualitative evaluations of all specimens for the presence of the DNA of 
AF in the lung tissue and BALs of the tested animals. 
2. Results and Discussion  
Histopathology  of  the  lungs  of  the  guinea  pigs  demonstrated  similar  findings  as  reported  by  
Vallor et al. [21] in which conidia were found in the pulmonary alveolar spaces within 1 hour. post 
infection.  As  noted  in  that  study,  guinea  pig  lungs  were  visibly  infected  with  Aspergillus  lesions 
compared to lungs obtained from uninfected animals. At one hour post infection, the mean pulmonary Int. J. Mol. Sci. 2012, 13  729 
 
 
fungal burden was assessed by semi-quantitative culture and revealed in this study to be a count of 
log10  4.23  +/−  0.7  CFU/g).  There  was  a  statistically  significant  decrease  in  the  fungal  burden 
demonstrated at day 3 through day 7, when compared to the 1 hour time point (Figure 1). 
Figure  1.  Comparison  of  infected  groups  to  numbers  of  Aspergillus  fumigatus  colony 
forming units (CFU) by culture present in the lung. 
 
All  data  in  Figure  1  are  presented  as  the  number  of  AF  CFUs  by  culture  and  were  detected  
(Log10/g  Lung)  upon sacrifice  of the  animal and removal  of the lung  tissue. This  evaluation was 
conducted with each animal infected and sacrificed one hour later through animals being sacrificed 
264 hours post-inoculation. Four uninfected animals were also used in this evaluation. 
In addition, this study also demonstrated that qualitative Realtime PCR is capable of detecting very 
small amounts of target specific DNA (Figure 2 and Figure 3). The curves shown, demonstrate the 
amplification efficiency of the assay being within the acceptable range of 90 to 105% and the linear 
standard curve (R
2) greater than 0.980. The AF assay limit of detection dilution series below shows the 
detection limit of the assay to be between approximately 6 ×  10
4 copies to 6 copies of purchased AF 
genomic DNA (See explanation in Materials and Methods)  
Approximately  2.0  µ g  of  AF  DNA  was  acquired  from  the  American  Type  Culture  Collection 
(ATCC #1022 D-2). The approximate copy number was determined based on information provided by 
ATCC and the genome size of AF. The template was used in a five point dilution series ranging from  
6 ×  10
4 copies to 6 copies. All points of the serial dilution were detected by the ABI 7500 Fast with 
results demonstrated in Table 1. 
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Figure 2. Aspergillus fumigatus PCR dilution series demonstrating the qualitative detection limit.  
 
Figure  3. Aspergillus fumigatus PCR dilution Standard Curve demonstrating efficiency 
and linearity. 
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Table 1. Results by qualitative Realtime PCR assay of an Aspergillus fumigatus dilution 
series ranging from approximately 6 ×  10
4 copies to 6 copies. 
Points  Approximate concentration of each Point  Result 
1  6 ×  10
4 Copies  Detected 
2  6 ×  10
3 Copies  Detected 
3  6 ×  10
2 Copies  Detected 
4  6 ×  10 Copies  Detected 
5  6 Copies  Detected 
Utilizing the qualitative Realtime PCR assay above, the guinea pig bronchoalveolar lavages and 
lung tissue were evaluated for the presence of AF DNA. Results of these studies demonstrated that AF 
DNA could be detected in BALs and lung tissue within the detection limits described above (Table 2). 
Table  2.  Detection  of  Aspergillus  fumigatus  DNA  in  lung  homogenates  and 
bronchoalveolar lavage (BAL).  
Animal 
Identification 
Infection Group 
Time Animals 
Sacrificed 
After infection 
A. fumigatus DNA 
Detected in Lung 
homogenates 
A. fumigatus 
DNA Detected 
in BAL 
04GP-1  Infected  At 1 hour  Positive  Positive 
04GP-2  Infected  At 1 hour  Positive  Positive 
04GP-3  Infected  At 1 hour  Positive  Positive 
04GP-4  Infected  At 1 hour  Positive  Positive 
04GP-5  Infected  At 1 hour  Positive  Positive 
04GP-6  Infected  At 72 hours  Positive  Positive 
04GP-7  Infected  At 72 hours  Positive  Positive 
04GP-8  Infected  At 72 hours  Positive  Positive 
04GP-9  Infected  At 72 hours  Positive  Positive 
04GP-10  Infected  At 72 hours  Positive  Positive 
04GP-11  Infected  At 120 hours  Positive  Positive 
04GP-12  Infected  At 120 hours  Positive  Positive 
04GP-13  Infected  At 120 hours  Positive  Positive 
04GP-14  Infected  At 120 hours  Positive  Positive 
04GP-15  Infected  At 120 hours  Positive  Positive 
04GP-27  Infected  At 168 hours  Positive  Positive 
04GP-24  Infected  At 264 hours  Positive  Positive 
04GP-26  Infected  At 264 hours  Positive  Positive 
04GP-31  Not infected  At 264 hours  Not detected  Not detected 
04GP-32  Not infected  At 264 hours  Not detected  Not detected 
04GP-34  Not infected  At 264 hours  Not detected  Not detected 
04GP-35  Not infected  At 264 hours  Not detected  Not detected 
Conidia were detected by histopathology in the pulmonary alveolar spaces of the guinea pigs within 
1  hour  post  infection,  confirming  the  results of  Vallor  et  al.  [21].  Also,  as  seen  in  the  previous  
study [21], by day 5 post infection, guinea pig lungs showed Aspergillus lesions when comparing them 
to lungs of non-infected animals. These same findings were noted in this study, thus demonstrating the Int. J. Mol. Sci. 2012, 13  732 
 
 
reproducibility of the described animal model. Furthermore, this study determined that when an animal 
is infected with AF, the same organism can be detected by qualitative Realtime PCR in the BALs and 
lungs. This information could be extremely useful and important in determining the efficacy of many 
antifungals which may be used in patients who have fungal positive BALs. These studies may be used 
further to calculate the number of copies to determine prolonging survival when determining efficacy 
of drugs used in patients who have undergone transplantation or those immunocompromised patients 
who may succumb to infection by what was initially very few organisms. The results of this study may 
be expanded to observe the presence or absence of mycotoxins produced by Aspergillus sp. (not just 
AF),  and  to  determine  the  number  of  copies  of  fungi  needed  to  actually  produce  a  significant, 
detectable amount of mycotoxin in a clinical specimen.  
3. Experimental Section  
3.1. Animals and Immunosuppression 
The animal model assessment of AF burden in guinea pigs has been previously described [21]. 
Briefly, 8 male Harley guinea pigs (0.5 kg; Charles River Laboratories, Wilmington, MA) were made 
neutropenic with intraperitoneal cyclophosphamide (250 mg/kg; Cytoxan; Mead Johnson, Princeton, 
NJ, USA) and further immunosuppressed with cortisone acetate (250 mg/kg; Sigma, St Louis, MO, 
USA) given subcutaneously 2 days prior to inhalational challenge In addition, ceftazidime (100 mg/kg 
by subcutaneous injections; Glaxo SmithKline Beecham Pharmaceuticals, Philadelphia, PA, USA) was 
administered daily throughout the study for prevention of bacterial infections. In order to maintain 
immunosuppression  throughout  the  study,  additional  doses  of  cyclophosphamide  (200  mg/kg)  and 
cortisone acetate (250 mg/kg) were administered on day 3 post inhalational challenge. All animal 
research  procedures  were  approved  by  the  Institutional  Animal  Care  and  Use  Committee  at  the 
University of Texas Health Science Center at San Antonio, and animals were maintained in accordance 
with the American Association for Accreditation of Laboratory Animal Care.  
3.2. Preparation of Inoculate and Inhalational Challenge 
The  preparation  of  AF  (AF293)  has  been  previously  described  [21]  as  has  the  inhalational  
challenge [22–24]. Briefly, the organism was cultured; conidia were dislodged from potato dextrose 
plates, spun in Sorvall centrifuge and, filtered, by approved protocol [21]. A portable, acrylic chamber 
was used to establish the model of invasive pulmonary aspergillosis (IPA) [23], and was used in this 
study. The acrylic chamber was used to simultaneously infect groups of guinea pigs with nebulized 
inocula of 10
8 CFU/mL of AF conidia (total volume was 12 mL). Eighteen animals were exposed to 
the aerosol mist for 1 hour. After one additional hour, five guinea pigs were sacrificed to confirm and 
assess  the  average  conidial  delivery  of  the  infected  run.  Guinea  pigs  were  sacrificed  by  terminal 
exsanguinations after being anesthetized with 44 mg/kg ketamine-HCl and 10 mg/kg xylazine. A cohort 
of four immunosuppressed guinea pigs was left uninfected but underwent the same immunosuppression 
and placebo therapeutic regimen as the infected cohort. After sacrifice, lungs, liver, kidney, brain, 
bladder, spleen, and serum were collected from each animal. Saline injections to obtain BALs were Int. J. Mol. Sci. 2012, 13  733 
 
 
performed prior to exsanguinations from all animals. Only lung homogenates and BAL results were 
reported in this study. 
3.3. Fungal Burden Assessment  
Fungal burdens in the lungs of the 15 guinea pigs were determined by CFU counting using the same 
methods as  previous reported [21]. Guinea pigs were infected with 2.3  ×  10
7 CFU/mL of  AF by 
aerosolization as previously described [21]. 
3.4. AF Qualitative Realtime PCR Detection Limits 
Lyophilized  AF  genomic DNA (strain  NRRL 163)  was acquired from  ATCC to  determine the 
detection  limits  of  the  AF  Realtime  PCR  assay.  The  lyophilized  genomic  DNA  (approximately  
6.18  ×  10
7  copies)  was  rehydrated  in  100.0  µ L  of  PCR  grade  water  for  a  final  concentration  of 
approximately  6  ×  10
5  copies/µ L.  This  DNA  solution  was  used  to  setup  a  dilution  series  from 
approximately 6 ×  10
4 copies/µ L to 6 copies/µ L. Upon completion of the dilution series, 1.0 µ L of 
each dilution series point was used in a Realtime PCR reaction.  
3.5. Extraction and Qualitative Realtime PCR assessment of AF 
To  ensure  maximum  recovery  of  fungal  DNA,  lung  homogenates  and  BALs  were  further 
homogenized using silica beads and a bead beating technique (Sigma, St. Louis, MO, USA) in order to 
ensure cellular release of genomic nucleic acid from all of the AF conidial and hyphal forms present. 
One milliliter (1.0 mL) aliquots of lung homogenates or BALs were subjected to sterile bead beating 
for  1.0  minute  (Mini  Bead  Beater,  BioSpec  Products,  Bartlesville,  OK,  USA)  as  previously  
described [21]. Homogenized samples were processed for DNA extraction using the QIAamp DNA 
Mini Kit (Qiagen, Valencia, CA, USA) according to the manufacturer’s directions. Purified DNA was 
obtained for all samples processed with the purified DNA used as templates for qualitative Realtime 
PCR analysis. Proprietary primers and a probe specific for AF plus an internal control assay were 
designed by RealTime Labs, Inc. and synthesized by Integrated DNA Technologies, Inc. (Coralville, 
IA, USA). Primers were synthesized at a scale of 25 nm and probes were synthesized at a scale of 100 nm.  
3.6. Assay Controls and Reaction Details 
The test was further controlled by using internal controls of Geotrichum sp. (GEO) and known 
positive controls of AF as well as known negative samples. The characteristics of the DNA probe and 
primers in this study were forward primer size: 20 base pairs (bp); reverse primer size 20 bp; and probe 
size 26 bp. All probes used for the assays were hydrolysis probes with the reporter fluorescent reporter 
dye,  6-carboxy-fluorescein  (FAM) attached to  the  5’  end  and  the  quencher  Black  Hole  Quencher 
(BHQ-1) attached to the 3’ end. Primers and probes were received lyophilized and re-suspended into 
100 µ M stocks. These stocks were then mixed into working stocks containing probe and primers at 
required concentrations. The enzyme and reaction buffers used in the reaction were purchased from 
Cepheid manufactured specifically for the SmartCycler
® system and Applied Biosystems manufactured 
specifically for the 7500 FAST. The reactions were set up per manufacturer recommendations. An Int. J. Mol. Sci. 2012, 13  734 
 
 
internal control assay was run for each extracted sample to insure the sample extracted generated 
purified DNA and was present in the reaction and contained no inhibitors. Additionally, a positive 
control and negative control was run for each assay to insure that each fungal Realtime PCR assay 
component  was  amplifying  and  detecting  the  target  and  that  there  were  no  problems  with 
contamination. All assays and the internal control had a cycling profile containing an initial hot start 
followed by 45 denature and  anneal  cycles.  All  assays  were designed and  operated  as  qualitative 
detection assays and were able to determine the presence or absence of fungal DNA specific to the 
assay used in the reaction.  
3.7. Histological Evaluation 
Samples of guinea pig lungs were aseptically removed and fixed in 10% neutral buffered formalin. 
Paraffin-embedded  tissue  sections  were  then  sectioned  and  stained  with  Grocott-Gomori 
methenamine-silver stain (GMS) and Hematoxylin-Eosin (H and E) stain (Tissue Techniques, Inc., 
Dallas, TX, USA) for evaluation of the inflammatory response in the immunosuppressed animals as 
well as for the presence of the fungal organisms.  
3.8. BAL and Lung Homogenate Evaluation 
Five hundred microliters of BALs and frozen tissue from lungs as well as 500 µ L of homogenized 
lung tissue in saline from the guinea pigs were sent to RTL from the University of Texas Health 
Science Center at San Antonio on dry ice. Three hundred microliters of BAL and 300 µ L of lung 
homogenate were centrifuged at  
13,000 rpm for 10 minutes (AcuSpin, microcentrifuge, Fisher Scientific, Germany). The supernatant 
was removed and the pellet was re-suspended in 50 µ L of normal saline and vortexed for 15 seconds. 
Fifty microliters of the sediment was placed on a glass microscopic slide and a drop of Lactophenol 
Cotton Blue was added to the sediment. A cover slip was placed on the sample and observed under low 
power. Spores were counted using a hemocytometer. Results of the spore count are seen in Figure 1. 
Hyphal elements were also noted. 
4. Conclusions  
This study shows that guinea pigs infected with AF by use of an aerosol mist had detectable fungal 
burden in their lungs up to 11 days following infection. It was also determined that AF DNA could be 
detected  utilizing  qualitative  Realtime  PCR  in  both  bronchoalveolar  lavage  and  lung  tissue  up  to  
11 days following infection. Lastly, the detection limit of the qualitative Realtime PCR assay was 
shown experimentally. 
Realtime PCR is a powerful tool for determining the presence or absence of specific fungal targets 
in body fluids and tissue. Because blood cultures are rarely positive in Aspergillosis, the technology 
described here has the capability to detect down to one copy of DNA and has the practical ability to 
routinely detect down to 10 copies of DNA. This study has shown that specific Realtime PCR DNA 
probes and primers can be utilized in qualitative studies of body fluids and tissues, specifically BALs, 
to determine the presence or absence of AF DNA within the detection limits of the assay. Realtime Int. J. Mol. Sci. 2012, 13  735 
 
 
PCR in combination with a well-designed target specific assay can and will be useful when evaluating 
transplant  patients  or  immunocompromised  patients  for  the  presence  of  potentially  lethal  fungal 
organisms.  This  diagnostic  ability  will  lead  to  more  successful  transplants  accompanied  by  fewer 
patient complications and deaths. 
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